title: Mattress cerclage combined with electrochemical therapy and pingyangmycin injection after embolization for management of arteriovenous malformation on oral and maxillofacial region.
abstract: BACKGROUND
  The purpose of the article was to assess the clinical results of mattress cerclage combined with electrochemical therapy and pingyangmycin injection after embolization in treating arteriovenous malformations (AVMs).
  
  
  METHODS
  During the period from January 2008 to December 2012, a total of 26 patients with AVMs were treated through mattress cerclage combined with electrochemical therapy and pingyangmycin injection after embolization and were retrospectively examined. The size of the lesions ranged from 2.5 cm × 3 cm to 8 cm × 10 cm. The follow-up time varied from 8 months to 24 months. The clinical outcome was evaluated using a 4-grade scale.
  
  
  RESULTS
  All the lesions decreased in size after the treatment. The clinical follow-up showed excellent response in 20 of the 26 patients, whereas the remaining 6 patients also had satisfactory response. The most common complication was swelling, followed by pain and fever, without serious adverse effects being encountered.
  
  
  CONCLUSIONS
  Mattress cerclage combined with electrochemical therapy and pingyangmycin injection after embolization was a reliable method for AVMs.
authors.affiliation: From the Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University, Shenyang, Liao Ning Province, People's Republic of China.
authors.forename: Chen
authors.initials: C
authors.lastname: Cheng
authors.forename: Shan-Long
authors.initials: SL
authors.lastname: Xi
authors.forename: Da-Peng
authors.initials: DP
authors.lastname: Xu
authors.forename: Qin-Kai
authors.initials: QK
authors.lastname: Zhai
authors.forename: He
authors.initials: H
authors.lastname: Gong
authors.forename: Xu-Kai
authors.initials: XK
authors.lastname: Wang
mesh_terms: D000293:Adolescent; D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D001165:Arteriovenous Malformations / Q000628:therapy*; D001761:Bleomycin / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002648:Child; D019468:Disease Management; D055664:Electrochemical Techniques / Q000379:methods*; D004621:Embolization, Therapeutic / Q000379:methods*; D005145:Face / Q000098:blood supply*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000903:Antibiotics, Antineoplastic; D001761:Bleomycin; C025703:bleomycetin